Methods for treating hyperopia and presbyopia via laser tunneling
View Patent ↗A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
1. A surgical method for treating an eye in need of one or more of a physiological or a vision correction, comprising:
providing a treatment source which includes a laser and which is suitable for cutting or ablating an anatomical structure of an eye;
determining an ablation endpoint that extends through a thickness of the structure;
delivering a spot size, of energy, greater than about 0.8 mm from the treatment source onto the structure in at least one vicinity of the structure that does not contact a surgical limbus of the eye; and
ablating through more than 90% of the thickness of the structure until a hue in an area of the structure being ablated visibly changes, to form sets of tunnel ablations between, but not overlapping, superior, medial, inferior and lateral rectus muscles of the eye.
2. The surgical method as set forth in claim 1 , wherein the tunnel ablation extends through 91% to 100% of the thickness of the sclera but not into the choroid to cause hypotonia, and has a u-shaped or flattened bottom surface.
3. The surgical method as set forth in claim 1 , wherein the tunnel ablation is formed to have a width on the surface, measured in a direction parallel to the surface, greater than 0.8 mm.
4. The surgical method as set forth in claim 3 , wherein the tunnel ablation is formed to have a length on the surface, measured in a direction parallel to the surface, greater than 5.25 mm.
5. The surgical method as set forth in claim 1 , wherein:
the eye is in need of a vision correction; and
the surgical method restores an accommodation to the eye.
6. The surgical method as set forth in claim 5 , wherein the treatment source is an Er, Cr:YSGG laser.
7. The surgical method as set forth in claim 5 , wherein:
the treatment source has a spot size on the surface that is greater than about 0.8 mm; and
the ablating comprises forming a tunnel ablation having a u-shaped or flattened bottom surface with a radius of curvature greater than about 75 mm.
8. The surgical method as set forth in claim 1 , wherein the tunnel ablation has a u-shaped bottom surface.
9. The surgical method as set forth in claim 1 , wherein the treatment source has a spot size on a scleral surface that is greater than about 0.8 mm.
10. The surgical method as set forth in claim 1 , wherein the delivering comprises:
directing energy from the treatment source onto the sclera in vicinities of the sclera other than occupied vicinities, which correspond to areas of a rectus muscles of the eye; and
generating sets of tunnel ablations between occupied vicinities in portions of the sclera other than those comprising the rectus muscles.
11. The surgical method as set forth in claim 10 , wherein a plurality of elongate tunnel ablations is formed between each of the occupied vicinities.
12. The surgical method as set forth in claim 10 , wherein each set of tunnel ablations comprises two elongated, substantially parallel tunnel ablations.
13. The surgical method as set forth in claim 10 , wherein the tunnel ablations of each set have widths on a surface of the sclera of about 0.4 to 1.5 mm and have longer lengths, and wherein the tunnel ablations of each set are formed to have an initial or marked separation of about 2 mm.
14. The surgical method as set forth in claim 13 , wherein the elongated tunnel ablations of each set are substantially parallel to one another and, following formation, are separated by a distance of about 1.8 to 1.2 mm.
15. The surgical method as set forth in claim 10 , wherein:
the elongated tunnel ablations of each set have widths on a surface of the sclera greater than 0.8 mm, and
the elongated tunnel ablations of each set are separated by a distance of about 0.5 mm of more.
16. The surgical method as set forth in claim 10 , wherein each set of tunnel ablations extends at least 95% through the sclera.
17. The surgical method as set forth in claim 10 , further comprising identifying, detecting or determining one or more of a depth of the patient's sclera, a level of sclerosis of the sclera, a severity of the presence of strictures in the scleral, a loss of scleral tissue elasticity, a size of the patient's eye, a location of the patient's rectus muscles, a size of the pupil, and a quality of the tissue surrounding the proximal adjacent choroid of the eye.
18. The surgical method as set forth in claim 17 , wherein:
the determining of an ablation endpoint comprises determining an ablation endpoint as a depth at which the tunnel ablation is to be formed with the treatment source into the sclera;
the ablation endpoint is based upon an estimated thickness of the sclera along a line generally transverse to a surface of the sclera;
the focused energy from the treatment source is emitted in a direction having as at least a component thereof the line; and
the ablating is ceased, based upon the estimated thickness and the determined ablation endpoint.
19. The surgical method as set forth in claim 1 , the tunnel ablation has a radius of curvature greater than about 75 mm.
20. The surgical method as set forth in claim 1 , wherein the delivering of energy comprises focusing energy from the treatment source onto the sclera.
21. The surgical method as set forth in claim 1 , wherein the determining of an ablation endpoint comprises determining an ablation endpoint corresponding to a depth at which the tunnel ablation is to be formed with the treatment source into the sclera.
22. The surgical method as set forth in claim 1 , wherein the determining of an ablation endpoint comprises determining an ablation endpoint as to a depth at which the tunnel ablation is to be formed into the sclera.
23. The surgical method as set forth in claim 1 , wherein the determining of an ablation endpoint is performed prior to the ablating.
24. A surgical method for treating an eye in need of one or more of a physiological or a vision correction, comprising:
providing a treatment source which includes a laser and which is suitable for cutting or ablating an anatomical structure of an eye;
delivering energy from the treatment source onto the structure in at least one vicinity of the structure that does not contact a surgical limbus of the eye; and
ablating through more than 90% of the thickness of the structure to form a tunnel ablation, whereby an ablation endpoint is determined by a user at a detected changing of hue in an area of the structure being ablated.